The FDA has not issued orders to discontinue compounded semaglutide, though regulatory scrutiny of GLP-1 compounding has increased following shortages of brand-name Ozempic and Wegovy
Niles prides herself on the delivery of quality medical care
Gene expression data were generated with the Illumina HumanHT-12 V3.0 expression beadchip (Platform GPL6947)
The SURMOUNT-5 data on waist circumference is also clinically meaningful: research has shown that each 5-centimeter increase in waist circumference corresponds to a 7 to 9 percent increase in mortality risk, making the 5.4-centimeter additional reduction with tirzepatide a potentially significant benefit.1 That said, semaglutide remains highly effective and is still the right choice for many patients, depending on insurance coverage, cost, tolerance, and individual response
it impacts your metabolism, bone density, balance, and long-term health
Zealthy makes healthcare affordable, fast, and private so you can focus on results, not red tape